Live from the NIH registry
Studies recruiting near Brownsville right now
Top 25 of 61 recruiting studies, sorted by proximity — each links to its official registry page
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Urothelial Cancer, Advanced/Metastatic Urothelial Cancer
Phase 1, Phase 2
Interventional 132 participants sought
Texas Oncology - Central/South Texas — Harlingen, Texas (19.9 mi)
· Sponsor: Pfizer
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Obesity
Phase 3
Interventional 1,200 participants sought
Kailera Clinical Site — Brownsville, Texas (7.1 mi)
· Sponsor: Kailera
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
Cerebral Vasospasm, Aneurysmal Subarachnoid Hemorrhage (aSAH)
N/A
Observational 200 participants sought
Valley Baptist Medical Center- Harlingen — Harlingen, Texas (19.9 mi)
· Sponsor: Vesalio
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Myositis
Phase 3
Interventional 318 participants sought
Integrative Rheumatology of South Texas — Harlingen, Texas (19.9 mi)
· Sponsor: Pfizer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
Texas Oncology- Central South — Harlingen, Texas (19.9 mi)
· Sponsor: Pfizer
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Lupus Nephritis
Phase 4
Interventional 150 participants sought
Integrative Rheumatology of South Texas — Harlingen, Texas (19.9 mi)
· Sponsor: Aurinia Pharmaceuticals Inc.
A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
Obesity, Overweight
Phase 2
Interventional 300 participants sought
South Texas Research Institute - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Boehringer Ingelheim
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
Acute Ischemic Stroke
Phase 2
Interventional 228 participants sought
Valley Baptist Medical Center - Harlingen — Harlingen, Texas (19.9 mi)
· Sponsor: Basking Biosciences, Inc.
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Phase 3
Interventional 1,000 participants sought
Local Institution - 0305 — Harlingen, Texas (19.9 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Pneumococcal Disease
Phase 3
Interventional 3,230 participants sought
Proactive RGV — Brownsville, Texas (7.1 mi)
· Sponsor: Pfizer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma
Phase 1, Phase 2
Interventional 224 participants sought
Texas Oncology - Central South — Harlingen, Texas (19.9 mi)
· Sponsor: Pfizer
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
COPD
Phase 2
Interventional 171 participants sought
Proactive RGV — Brownsville, Texas (7.1 mi)
· Sponsor: Uniquity One (UNI)
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Brownsville, Texas (7.1 mi)
· Sponsor: Akero Therapeutics, Inc
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Phase 3
Interventional 980 participants sought
Valley Institute of Research: 8400004 — Harlingen, Texas (19.9 mi)
· Sponsor: Sanofi
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Brownsville, Texas (7.1 mi)
· Sponsor: 89bio, Inc.
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
American Arthritis and Rheumatology Associates-Tx PLLC — Harlingen, Texas (19.9 mi)
· Sponsor: University of Alabama at Birmingham
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
South Texas Research Institute - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Boehringer Ingelheim
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
Spinal Cord Injuries
N/A
Interventional 40 participants sought
University of Texas - Rio Grande Valley — Harlingen, Texas (19.9 mi)
· Sponsor: University of Minnesota
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
PreDiabetes
Phase 4
Interventional 300 participants sought
UTHealth Clinical Research Unit (CRU) at UT Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: The University of Texas Health Science Center, Houston
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
Alcohol Liver Disease
Phase 2
Interventional 100 participants sought
Altimmune Clinical Study Site — Brownsville, Texas (7.1 mi)
· Sponsor: Altimmune, Inc.
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohn Disease
Phase 2
Interventional 212 participants sought
Texas Digestive Specialists — Harlingen, Texas (19.9 mi)
· Sponsor: Abivax S.A.
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
Eosinophilic Esophagitis
Phase 3
Interventional 308 participants sought
Dr. Falk Investigational Site — Harlingen, Texas (19.9 mi)
· Sponsor: Dr. Falk Pharma GmbH
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Phase 3
Interventional 660 participants sought
USOR - Texas Oncology — Harlingen, Texas (19.9 mi)
· Sponsor: Genmab
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
South Texas Research Institute (STRI) - Brownsville — Brownsville, Texas (7.1 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism
Primary Hyperaldosteronism
Phase 3
Interventional 250 participants sought
Research Site — Brownsville, Texas (7.1 mi)
· Sponsor: AstraZeneca